This randomized controlled trial investigated the effects of structured triglycerides (STGs) containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) esterified with medium-chain triglycerides (MCTs) versus physical mixtures (PMs) of EPA and MCTs. The study population consisted of 28 healthy young men, and the follow-up period was 8 weeks. The primary outcome measured was blood EPA levels, specifically the serum EPA/arachidonic acid (AA) ratio. Secondary outcomes included muscular endurance, fatigue, repetition counts, maximal voluntary contraction, range of motion, thigh circumference, muscle thickness, echo intensity, and jump performance.
Results indicated a significantly greater increase in the serum EPA/arachidonic acid (AA) ratio in the STG group compared with the PM group. In contrast, no significant differences were found between groups regarding repetition counts or fatigue-related measures. Absolute numbers, effect sizes, and p-values were not reported for these outcomes.
Safety and tolerability data were not reported, and adverse events, serious adverse events, and discontinuations were not reported. The study limitations include the uncertainty regarding whether STGs have superior effects on blood EPA levels and muscular endurance and fatigue. Funding or conflicts of interest were not reported.
View Original Abstract ↓
BACKGROUND: Structured triglycerides (STGs), in which eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are esterified with medium-chain triglycerides (MCTs), have demonstrated greater bioavailability and potential benefits in improving endurance and reducing post-exercise strength loss compared with physical mixtures (PMs) of EPA and MCTs. However, it remains unclear whether STGs have superior effects on blood EPA levels and muscular endurance and fatigue. This study compared the effects of 8-week STG and PM intake on blood EPA levels, muscular endurance, and fatigue following resistance exercise.
METHODS: Twenty-eight healthy young men were randomly assigned to an STG group (n = 15) or a PM group (n = 13) in a double-blind, parallel-group, active comparator trial. Participants consumed 4,560 mg/day of the test oil (600 mg EPA, 260 mg DHA) for 8 weeks. After the intervention, the participants performed four sets of leg extensions to exhaustion at 40% of their body weight. Muscular endurance was assessed by the number of repetitions, and fatigue was evaluated by changes in maximal voluntary contraction, range of motion, thigh circumference, muscle thickness, echo intensity, and jump performance.
RESULTS: The STG group showed a significantly greater increase in the serum EPA/arachidonic acid (AA) ratio compared with the PM group. However, no significant differences were found between groups in repetition counts or fatigue-related measures.
CONCLUSION: Eight weeks of STG supplementation improved the blood EPA/AA ratio more than a PM, but did not yield superior effects on muscle endurance or fatigue.